FDA Inspection 988733 — Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated — FEI 1000513211

The FDA completed an inspection of Vertex Pharmaceuticals Incorporated on September 21, 2016 in Boston, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 21, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Boston, MA (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
184421 CFR 211.84(d)(2)Establish reliability of supplier's C of A